Covid-19: current knowledge, disease potential, prevention and clinical advances

The top priority of any nation is to lead the nation towards prosperity, progress, and economic growth, confronting several challenges and concerns arisen from global situations. The sudden outbreak of any disease defies the health care systems and economy of nations. COVID-19 is one of the viral diseases which broke out in Wuhan city of China in 2019. COVID-19 outbreak intermittently prevailed all over the world. It exposes the fragility of the established health care systems across the world in spite of comprising modern science and technology. Unfortunately, there is no chemotherapeutic agent in the regimen of antiviral drugs or no vaccine available to curb this infectious disease. As a consequence, this deadly infection has prevailed all over the world. The antiviral drugs used for viral diseases excluding COVID-19 infection are Ramdesvir, Favipiravir, and Ribavarin, and antimalarial agents (Chloroquine & Hydroxychloroquine) are being administered to the patients for redemption of this infection. Fortunately, these existing drugs have been found clinically active and are being used. In this review, we present the current scenario and status of epidemiology, diagnosis, treatment, vaccine development for COVID-19, and its impact on the socio-economic structure.

___

  • Alam A, 2017, BIOMED PHARMACOTHER, V91, P1152, DOI 10.1016/j.biopha.2017.05.045
  • Arabi YM, 2018, TRIALS, V19, DOI 10.1186/s13063-017-2427-0
  • Barton C, 2014, ANTIMICROB AGENTS CH, V58, P120, DOI 10.1128/AAC.01407-13
  • Chan JFW, 2015, CLIN MICROBIOL REV, V28, P465, DOI 10.1128/CMR.00102-14
  • Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
  • Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
  • Cheng KW, 2015, ANTIVIR RES, V115, P9, DOI 10.1016/j.antiviral.2014.12.011
  • Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07
  • Chhikara B. S., 2020, CHEM BIOL LETT, V7, P63, DOI DOI 10.1007/s00058-020-1496-8
  • Cohen FS, 2016, BIOPHYS J, V110, P1028, DOI 10.1016/j.bpj.2016.02.006
  • Cohen J, 2020, SCIENCE, DOI [10.1126/science.abb0611, DOI 10.1126/SCIENCE.ABB0611]
  • Cyranoski David, 2020, Nature, DOI 10.1038/d41586-020-00364-2
  • De Clercq E, 2019, CHEM-ASIAN J, V14, P3962, DOI 10.1002/asia.201900841
  • de Wilde AH, 2018, CURR TOP MICROBIOL, V419, P1, DOI 10.1007/82_2017_25
  • de Wilde AH, 2017, VIRUS RES, V228, P7, DOI 10.1016/j.virusres.2016.11.011
  • de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81
  • Eltahla AA, 2015, VIRUSES-BASEL, V7, P5206, DOI 10.3390/v7102868
  • Falzarano D, 2013, NAT MED, V19, P1313, DOI 10.1038/nm.3362
  • Gorbalenya A. E., 2020, BIORXIV PREPRINT, DOI [10.1101/2020.02.07.937862, DOI 10.1101/2020.02.07.937862, 10.1101/2020.02.07.937862v1]
  • Hart BJ, 2014, J GEN VIROL, V95, P571, DOI 10.1099/vir.0.061911-0
  • Holshue Michelle L, 2020, N Engl J Med, V382, P929, DOI 10.1056/NEJMoa2001191
  • Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
  • Ito K, 2016, J GASTROEN HEPATOL, V31, P180, DOI 10.1111/jgh.13030
  • Ji W, 2020, J MED VIROL, V92, P433, DOI 10.1002/jmv.25682
  • Ju J, 2020, BIORXIV, DOI [10.1101/2020.03.12.989186, DOI 10.1101/2020.03.12.989186]
  • Kim UJ, 2016, ANTIVIR THER, V21, P455, DOI 10.3851/IMP3002
  • Kindrachuk J, 2015, ANTIMICROB AGENTS CH, V59, P1088, DOI 10.1128/AAC.03659-14
  • Li GD, 2020, NAT REV DRUG DISCOV, V19, P149, DOI 10.1038/d41573-020-00016-0
  • Li Hongying, 2019, Biosaf Health, V1, P84, DOI 10.1016/j.bsheal.2019.10.004
  • Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8
  • Magagnoli Joseph, 2020, medRxiv, DOI [10.1016/j.medj.2020.06.001, 10.1101/2020.04.16.20065920]
  • Morse JS, 2020, CHEMBIOCHEM, V21, P730, DOI 10.1002/cbic.202000047
  • Muller C, 2018, ANTIVIR RES, V150, P123, DOI 10.1016/j.antiviral.2017.12.010
  • O'Keefe BR, 2010, J VIROL, V84, P2511, DOI 10.1128/JVI.02322-09
  • Oberg B, 2006, ANTIVIR RES, V71, P90, DOI 10.1016/j.antiviral.2006.05.012
  • Pfefferle S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002331
  • Rossignol JF, 2014, ANTIVIR RES, V110, P94, DOI 10.1016/j.antiviral.2014.07.014
  • Sheahan TP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13940-6
  • Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
  • Wang N, 2018, VIROL SIN, V33, P104, DOI 10.1007/s12250-018-0012-7
  • Wang WE, 2020, J MED VIROL, V92, P441, DOI 10.1002/jmv.25689
  • Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027
  • Zhou Y, 2015, ANTIVIR RES, V116, P76, DOI 10.1016/j.antiviral.2015.01.011
  • Zumla A, 2016, NAT REV DRUG DISCOV, V15, P327, DOI 10.1038/nrd.2015.37